GlassScriptPhysician profile
Audrey Obinero
NPI 1871935247
$635.02
in general payments reported to CMS, 2019-2025
17 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $294 · 2023: $24.76 · 2024: $70.25 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $140.62 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $102.10 | 2022-2023 | Glassia |
| Glaxosmithkline, LLC. | $59.07 | 2022-2024 | Trelegy Ellipta |
| Scilex Pharmaceuticals INC. | $35.67 | 2021 | |
| Exact Sciences Corporation | $33.42 | 2025 | The Cologuard Plus Collection Kit |
| Insulet Corporation | $29.05 | 2021 | |
| Philips North America LLC | $28.83 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.06 | 2022 | |
| Ani Pharmaceuticals, INC. | $24.25 | 2022 | |
| Viatris Specialty LLC | $22.94 | 2025 | Yupelri |
| Supernus Pharmaceuticals, INC. | $22.45 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $22.45 | 2025 | Zurzuvae |
| Janssen Pharmaceuticals, INC | $21.30 | 2024 | Xarelto |
| Biogen, INC. | $18.81 | 2025 | Skyclarys |
| Otsuka America Pharmaceutical, INC. | $18.00 | 2024 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.62 | 2024 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $14.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Obinero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.